Latest News about EXEL
Recent news which mentions EXEL
3 Biotech Stocks That Could Make You Richer
October 30, 2021
From Motley Fool
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
October 13, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter
September 28, 2021
From Motley Fool
Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation
September 20, 2021
Tickers
EXEL
From Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 2%
September 20, 2021
From Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
From Benzinga
2 Top Biotech Stocks to Buy Right Now
September 11, 2021
From Motley Fool
Is Exelixis Stock a Buy?
September 02, 2021
From Motley Fool
From Benzinga
From Motley Fool
7 Best Biotech Stocks to Buy in 2021 with Huge Upside
August 25, 2021
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 17, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 05, 2021
From Benzinga
Exelixis Files US Application For Expanded Use Of Cabometyx In Patients 12+ Years With Thyroid Cancer
August 05, 2021
Tickers
EXEL
From Benzinga
3 Top Stocks That'll Make You Richer in August (and Beyond)
August 02, 2021
From Motley Fool
From Benzinga
5 No-Brainer Stocks to Invest $500 In Right Now
July 26, 2021
From Motley Fool
2 Dirt Cheap Dividend Stocks You Can Buy Right Now
July 22, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
From Benzinga
The Smartest Stocks to Buy With $20 in July
July 16, 2021
From Motley Fool
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 14, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.